Assessment of effects of LY333334 [recombinant human parathyroid hormone (1-34)] on cortical bone using digital X-ray radiogrammetry.

被引：0
|
作者：
Hyldstrup, L
Jorgensen, JT
Gaich, G
机构：
[1] Univ Copenhagen, Hvidovre Hosp, Dept Endocrinol, Copenhagen, Denmark
[2] Pronosco AS, Vedbaek, Denmark
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
BONE | 2001年 / 28卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S97 / S98
页数：2
相关论文
共 50 条
  • [1] Early effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling and mechanical properties of cortical bone in rabbits
    Mashiba, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) : 804 - 804
  • [2] Effects of LY333334 [recombinant parathyroid hormone (1-34)] on cortical bone strength indices as assessed by peripheral quantitative computed tomography.
    Zanchetta, JR
    Bogado, C
    Ferretti, JL
    Wang, O
    Sato, M
    Gaich, GA
    BONE, 2001, 28 (05) : S86 - S86
  • [3] Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits
    Hirano, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (04) : 536 - 545
  • [4] Effects of LY333334 [recombinant human parathyroid hormone (1-34)] and alendronate sodium on markers of bone metabolism in postmenopausal women with osteoporosis.
    Body, JJ
    Gaich, GA
    Scheele, WH
    Kulkarni, PM
    Hodsman, AB
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S530 - S530
  • [5] Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys
    Brommage, R
    Hotchkiss, CE
    Lees, CJ
    Stancill, MW
    Hock, JM
    Jerome, CP
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10): : 3757 - 3763
  • [6] Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits
    Mashiba, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    BONE, 2001, 28 (05) : 538 - 547
  • [7] In vivo and in vitro comparison of LY333334, biosynthetic human parathyroid hormone (hPTH) (1-34), with synthetic hPTH(1-34).
    Black, EC
    Frolik, CA
    Hock, JM
    Cain, RL
    Chandrasekhar, S
    Harvey, AK
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : F370 - F370
  • [8] A randomized controlled clinical trial to compare the efficacy of LY333334 [recombinant human parathyroid hormone (1-34)] and alendronate sodium in postmenopausal women with osteoporosis.
    Body, JJ
    Gaich, GA
    Scheele, WH
    Miller, PD
    Kulkarni, PM
    Hodsman, AB
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S179 - S179
  • [9] Redistribution of vertebral bone mineral density after transient administration of recombinant human PTH(1-34), LY333334, in monkeys
    Turner, CH
    Hannum, B
    Gurdogan, O
    Clendenon, J
    Sato, M
    SIROT 99, 1999, : 721 - 724
  • [10] Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis
    Zanchetta, JR
    Bogado, CE
    Ferretti, JL
    Wang, O
    Wilson, MG
    Sato, M
    Gaich, GA
    Dalsky, GP
    Myers, SL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (03) : 539 - 543
12345